Daxor Corp (DXR)
8.97
+0.21
(+2.40%)
USD |
NASDAQ |
Nov 04, 13:06
Daxor Max Drawdown (5Y): 69.76% for Oct. 31, 2024
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
Date | Value |
---|---|
October 31, 2024 | 69.76% |
September 30, 2024 | 69.76% |
August 31, 2024 | 69.76% |
July 31, 2024 | 69.76% |
June 30, 2024 | 69.76% |
May 31, 2024 | 69.76% |
April 30, 2024 | 69.76% |
March 31, 2024 | 69.76% |
February 29, 2024 | 69.45% |
January 31, 2024 | 69.45% |
December 31, 2023 | 69.45% |
November 30, 2023 | 69.45% |
October 31, 2023 | 67.20% |
September 30, 2023 | 65.31% |
August 31, 2023 | 65.31% |
July 31, 2023 | 66.16% |
June 30, 2023 | 66.16% |
May 31, 2023 | 69.04% |
April 30, 2023 | 69.04% |
March 31, 2023 | 69.04% |
February 28, 2023 | 69.04% |
January 31, 2023 | 69.04% |
December 31, 2022 | 69.04% |
November 30, 2022 | 69.04% |
October 31, 2022 | 69.04% |
Date | Value |
---|---|
September 30, 2022 | 69.04% |
August 31, 2022 | 69.04% |
July 31, 2022 | 69.04% |
June 30, 2022 | 69.04% |
May 31, 2022 | 69.04% |
April 30, 2022 | 69.04% |
March 31, 2022 | 69.04% |
February 28, 2022 | 69.04% |
January 31, 2022 | 69.04% |
December 31, 2021 | 69.04% |
November 30, 2021 | 69.04% |
October 31, 2021 | 69.04% |
September 30, 2021 | 69.04% |
August 31, 2021 | 69.04% |
July 31, 2021 | 69.04% |
June 30, 2021 | 69.04% |
May 31, 2021 | 69.04% |
April 30, 2021 | 69.04% |
March 31, 2021 | 69.04% |
February 28, 2021 | 69.04% |
January 31, 2021 | 69.04% |
December 31, 2020 | 69.04% |
November 30, 2020 | 69.04% |
October 31, 2020 | 69.04% |
September 30, 2020 | 69.04% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
65.31%
Minimum
Aug 2023
69.76%
Maximum
Mar 2024
68.91%
Average
69.04%
Median
Nov 2019
Max Drawdown (5Y) Benchmarks
AptarGroup Inc | 39.77% |
Sanara MedTech Inc | 65.29% |
Precision Optics Corp Inc | 54.17% |
Warby Parker Inc | -- |
Perspective Therapeutics Inc | 91.70% |
Max Drawdown (5Y) Related Metrics
Alpha (5Y) | 3.278 |
Beta (5Y) | -0.541 |
Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 43.82% |
Historical Sharpe Ratio (5Y) | -0.0846 |
Historical Sortino (5Y) | -0.1769 |
Monthly Value at Risk (VaR) 5% (5Y Lookback) | 16.74% |